Global Peripheral Vascular Devices Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2024 - 2034
In the realm of treatments that bring about significant changes, in the medical field Peripheral Vascular Devices offer a wide array of instruments. Spanning from stents and balloon angioplasty tools to atherectomy and chronic total occlusion devices. Each of these tools is crafted to address artery and vein conditions in a manner that is efficient and minimally invasive.
Market Key Insights
- The Peripheral Vascular Devices market is projected to grow from $11.7 billion in 2024 to $55.0 billion in 2034. This represents a CAGR of 16.7%, reflecting rising demand across Vascular Angioplasty, Chronic Total Occlusion (CTO) Procedures and Aortic Aneurysm Repair.
Boston Scientific, Medtronic, and Abbott are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Peripheral Vascular Devices market and are expected to observe the growth CAGR of 16.0% to 23.4% between 2024 and 2030.
- Emerging markets including India, Brazil and and South Africa are expected to observe highest growth with CAGR ranging between 12.5% to 17.4%.
Transition like Shift towards Minimally Invasive Surgeries is expected to add $6.2 billion to the Peripheral Vascular Devices market growth by 2030
- The Peripheral Vascular Devices market is set to add $43.2 billion between 2024 and 2034, with manufacturer targeting Aneurysms & Venous Diseases Application projected to gain a larger market share.
- With
rising incidence of peripheral vascular diseases, and
tech-driven innovations in device design, Peripheral Vascular Devices market to expand 368% between 2024 and 2034.
Opportunities in the Peripheral Vascular Devices
Performing invasive treatments with devices for peripheral vascular conditions like angioplasty and stenting may be an overlooked segment in the market that shows promise, for growth as healthcare systems globally move towards minimally invasive treatment options.
Growth Opportunities in North America and Europe
North America Outlook
In the market scenario of peripheral vascular devices dominated by North America is driven by the high demand for solutions to address the widespread peripheral artery diseases in this region The strong market growth can be attributed to the advanced infrastructure and the significant presence of key industry players Competition is fierce in this market, with a handful of established companies holding sway providing openings for specialized markets and cutting edge technologies.
Europe Outlook
Additionally the peripheral vascular equipment market in Europe is showing results due to an aging population and a rise in health issues linked to smoking. Europe has a marketthat'squite divided with local and regional competitors, which leads to a competitive atmosphere. In this region there are prospects for expansion in markets that have not only yet been fully explored thanks to improvements, in healthcare facilities.
Market Dynamics and Supply Chain
Driver: Rising Incidence of Peripheral Vascular Diseases, and Greater Awareness and Accessibility to Treatment
Technological progress is also driving innovations in the field of healthcare equipment like drug eluting and bio absorbable implements and drug coated balloons . These advancements are also improving the performance and utility of Peripheral Vascular Devices. Gaining recognition, from healthcare experts.
Restraint: High Cost and Limited Reimbursement Policies
Opportunity: Advancements in Smart and Connected Devices and Expanding Applications in Geriatric Care
The elderly population facing long term health conditions and heart related issues represents a key area of expansion for the Peripheral Vascular Devices market. These tools offer treatment options that prioritize patient comfort and aim to shorten hospital stays, for older individuals.
Challenge: Lack of Awareness and Technical Know-How
Supply Chain Landscape
BASF AG
DowDuPont
Medtronic
Philips
Boston Scientific
Abbott Vascular
Johnson & Johnson
Cook Medical
BASF AG
DowDuPont
Medtronic
Philips
Boston Scientific
Abbott Vascular
Johnson & Johnson
Cook Medical
Applications of Peripheral Vascular Devices in Angioplasty, Chronic Total Occlusion (CTO) Procedures & Aortic Aneurysm Repair
Peripheral vascular devices are commonly used during angioplasty procedures to help widen narrowed or blocked blood vessels and restore normal blood flow to prevent potential health issues. Using PVDs offers an invasive approach to treatment reducing the risks linked with traditional surgical methods. Known companies, like Medtronic and Boston Scientific excel in developing these devices.
Peripheral vascular devices crucial in Endovascular Aneurysm Repair are utilized to insert stent grafts into the aorta for reinforcing the weakened vessel and averting ruptures effectively with their invasive approach and enhanced accuracy This leads to shortened recovery periods and better results for patients. The key contenders, in this field consist of Abbott Laboratories and Cook Medical.
Using PVD devices for performing CTO procedures aids in the removal of blockages in arteries, in both the heart and other parts of the body.
Recent Developments
Medtronic unveiled the BioMisics3D Stent System as part of its growing line of vascular products. This innovative system offers hope, for individuals suffering from artery disease.
Boston Scientific purchased VENIT Inc., a company known for its expertise, in stent technology. This acquisition aims to strengthen their presence in the vascular devices market.
Abbott Laboratories introduced the FlexNav Delivery System, a cutting edge technology designed to help doctors precisely place their vascular tools.
In the changing world of Peripheral Vascular Devices market trends are shifting due to technological breakthroughs and advancements in the field driven by the increasing occurrence of peripheral arterial disease . The rising demand, for improved devices is reshaping theindustry'strajectory towards an era.